Physician profile
Daniel K Witmer
NPI 1396005419
$4,938.41
in general payments reported to CMS, 2019-2025
8 companies · $854 in 2025
The $854 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,176 · 2020: $92.39 · 2021: $1,883 · 2022: $229 · 2023: $504 · 2024: $201 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,352.33 | 2019-2025 | Persona, Osseoti Reconstructive System |
| Stryker Corporation | $946.61 | 2019-2025 | Triathlon, Mako |
| Depuy Synthes Sales INC. | $173.68 | 2019-2021 | |
| Osteoremedies, LLC | $159.37 | 2025 | Remedy Spectrum Gv Spacer, Remedy Spacer, Osteoboost Select 5cc |
| Intellijoint Surgical INC. | $153.80 | 2019-2021 | |
| Amniox Medical, INC. | $102.50 | 2019 | |
| Smith+Nephew, INC. | $26.97 | 2021-2022 | |
| Molnlycke Health Care US, LLC | $23.15 | 2025 | Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Witmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.